E-Book Overview
This edition has totally revised chapters on drug regulation in the USA, with new contributor, Dr Peter Barton Hutt formerly FDA Special Counsel. New contributions regarding pharmaco-economics are covered in two new chapters. There are 22 chapters in all with contributions from pharmaceutical physicians, drug regulators, health economists and lawyers from UK, USA and Japan.
E-Book Content
The Textbook of Pharmaceutical Medicine, Fourth Edition
John P. Griffin John O' Grady, editors
BMJ Books
The Textbook of Pharmaceutical Medicine Fourth edition Edited by John P Griffin BSc, PhD, MBBS, FRCP, FRCPath, FFPM Chairman, John Griffin Associates Ltd. Director, Pharmadiligence Ltd. Visiting Professor, University of Surrey Postgraduate Medical School Former Director, Association of the British Pharmaceutical Industry, London Formerly Professional Head of the Medicines Division, DHSS, London and
John O’Grady MD, FRCP, FFPM, FBIRA, MRCPath Medical Director for Europe, Daiichi Pharmaceutical Co. Ltd., London Visiting Professor of Clinical Pharmacology, University of London
BMJ Books 2002 BMJ Books is an imprint of the BMJ Publishing Group All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording and/or otherwise, without the prior written permission of the publishers. First published by BMJ Books in 2002 BMA House, Tavistock Square, London WC1H 9JR All previous three editions were published by The Queen’s University of Belfast First edition published in 1993 Second edition published in 1994 Third edition published in 1998 www.bmjbooks.com British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library ISBN 0 7279 1523 1 Typeset by SIVA Math Setters, Chennai, India Printed and bound by MPG Books, Bodmin, Cornwall
Contents
Contributors Preface
v viii
Acknowledgements
ix
The editors
x
Part I:
1
Research and development
1
Discovery of new medicines Anand S Dutta
3
2
Pharmaceutical development Gavin Halbert
96
3
Toxicity testing David J Tweats, M David C Scales
128
4
Exploratory development John Posner
170
5
Clinical pharmacokinetics Paul Rolan
214
6
Clinical trials and good clinical practice Nigel Baber, John Sweatman
247
7
Medical statistics Kenneth D MacRae
358
8
Development of medicines: full development Alan G Davies, Peter D Stonier
395
Part II: 9 10
Medical department issues
421
The medical department Darrall L Higson
423
Medical marketing John H Young
436
iii
CONTENTS
11
Information and promotion D Michael Humphreys
456
12
The supply of unlicensed medicines for particular patient use John O’Grady, Amanda Wearing
491
13
Legal and ethical issues relating to medicinal products Christine H Bendall, Christopher JS Hodges
503
14
The safety of medicines A Peter Fletcher, Susan Shaw
532
Part III: 15
16
17
18
19
Regulatory aspects
The development of the control of human medicines in Europe from classical times to the year 2000 John P Griffin, Rashmi R Shah Technical requirements for registration of pharmaceuticals for human use: the ICH process and the common technical document Patrick F D’Arcy, Dean WG Harron The regulation of drug products by the United States Food and